IPF: Pirfenidone & Nintedanib as Treatment

IPF: Pirfenidone & Nintedanib as Treatment

“Dr. Timothy Whelan, Medical Director of the Lung Transplant Program from the Medical University of South Carolina, provides advice for two new drugs, Pirfenidone and Nintedanib, to slow the progression of IPF.” Read more about IPF and approved therapies: https://bit.ly/1lfMsiZ…

7 Articles On #Esbriet

1. Genentech’s PF Drug Esbriet Shown To Lower Mortality Rates in New Study   Read the article here: https://bit.ly/1URSd1G 2. Esbriet’s Promise and Potential as a PF Therapy   Read the article here: https://bit.ly/1kub6MJ 3. Phase III Trials…

IPF Disease Carries High Economic and Healthcare Burden

A retrospective study analyzing data on insurance claims from patients with idiopathic pulmonary fibrosis (IPF) revealed that the disease is associated with a significant economic and healthcare burden. The study, titled “Clinical and economic burden of idiopathic pulmonary fibrosis: a retrospective cohort study,” was published in the…

Lung Fibrosis in Newborn Rats Treated with Oxygen Eased by Drug Therapy

A new study from the Children’s Hospital of Chongqing Medical University, China, reports that the drug fasudil helps to prevent lung fibrosis development in newborn rats exposed to prolonged oxygen treatment by blocking the Rho/ROCK signaling pathway. While high levels of oxygen given to at-risk newborn infants is a life-saving procedure, researchers and clinicians know that prolonged exposure…